[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335385-105":59,"doc-detail-335385-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-prognostic-value-and-immunological-role-of-calciumcalmodulin-dependent-protein-kinase-kinase-2-camkk2-in-pan-cancer-study-observational-study","The prognostic value and immunological role of calcium/calmodulin dependent protein kinase kinase 2 (CAMKK2) in pan-cancer study - Observational study","","A multi-omics and clinical analysis assesses the prognostic value and immunological role of calcium/calmodulin dependent protein kinase kinase 2 (CAMKK2) across cancers. Gene variation profiling identifies abnormal high-frequency mutations in uterine corpus endometrial carcinoma, while expression analyses show comparatively high CAMKK2 levels in prostate adenocarcinoma. Aberrant CAMKK2 expression predicts survival outcomes in multiple cancer types and is linked to potential regulators including miR-129.1-3p and the small molecule EPZ004777. Single-cell transcriptomics further highlight elevated CAMKK2 expression in kidney renal clear cell carcinoma monocytes and macrophage M1 cells, and immunotherapy cohorts demonstrate longer overall survival associated with higher CAMKK2 in IMvigor210, with additional evidence of prognostic effects in other datasets.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-prognostic-value-and-immunological-role-of-calciumcalmodulin-dependent-protein-kinase-kinase-2-camkk2-in-pan-cancer-study-observational-study/335385/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-prognostic-value-and-immunological-role-of-calciumcalmodulin-dependent-protein-kinase-kinase-2-camkk2-in-pan-cancer-study-observational-study/335385.png","ImageObject",300,407,{"name":92,"@type":93},"River Wang","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-26","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main focus of this pan-cancer study on CAMKK2?","Question",{"text":112,"@type":113},"The study evaluates the prognostic value and immunological role of CAMKK2 across multiple cancer types using multi-omics and clinical data.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which cancers show notable CAMKK2 genetic or expression patterns?",{"text":117,"@type":113},"CAMKK2 shows abnormal high-frequency mutations in uterine corpus endometrial carcinoma, and relatively high expression levels in prostate adenocarcinoma.",{"name":119,"@type":110,"acceptedAnswer":120},"How is CAMKK2 related to survival and immunotherapy outcomes?",{"text":121,"@type":113},"Aberrant CAMKK2 expression predicts survival in several cancers. In the IMvigor210 immunotherapy cohort, patients with higher CAMKK2 expression have significantly longer median overall survival, and results suggest possible survival prolongation in other cohorts as well.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335385,1790179542,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","®  \n Observational Study   \nThe prognostic value and immunological role of calcium/calmodulin dependent protein kinasekinase 2 (CAMKK2) in pan-cancer study  \nSenjun Jin, MDa , Yanyan Wang, MDb , Sheng’an Hu, MDa , Guangzhao Yan, MDa ,*  \n\n| Abstract\u003Cbr>A thorough assessment of calcium/calmodulin dependent protein kinase kinase 2 (CAMKK2) in pan-cancer studies is currently absent. We integrate multi-omics and clinical data to conduct a molecular landscape of CAMKK2 . Gene variation results revealed abnormal high frequency mutations of CAMKK2 in uterine corpus endometrial carcinoma, while expression level analysis demonstrated relatively high expression of CAMKK2 in prostate adenocarcinoma. The aberrant expression of CAMKK2 was found to be predictive of survival outcomes in several cancer types. Additionally, we identified potential regulators of CAMKK2 expression, including miRNAs such as miR.129.1.3p, as well as small-molecule drugs such as EPZ004777, which significantly correlated with CAMKK2 expression. Single-cell transcriptome analysis of kidney renal clear cell carcinoma further revealed a significantly higher expression of CAMKK2 in and monocyte and macrophage M1 . Furthermore, in the kidney renal clear cell carcinoma IMvigor210 cohort, patients ongoing immunotherapy with higher CAMKK2 expression experienced a significantly longer median overall survival, but it was observed that in bladder urothelial carcinoma GSE176307 and skin cutaneous melanoma\u003Cbr>GSE78220 cohorts, CAMKK2 might significantly prolong overall survival. Briefly, CAMKK2 emerges as a promising molecular biomarker that holds potential implications for prognostic evaluation and predicting the effectiveness of immunotherapy across cancers. |\n| --- |\n| Abbreviations: BLCA = bladder urothelial carcinoma, BRCA = breast invasive carcinoma, CAMKK2 = calcium/calmodulindependent protein kinase kinase 2, CNV = copy number variations, GEO = Gene Expression Omnibus, HPA = Human Protein Atlas, HR = hazard ratios, KIRC = kidney renal clear cell carcinoma, KM = Kaplan–Meier, LGG = lower grade glioma, LIHC = liver hepatocellular carcinoma, LUSC = lung squamous cell carcinoma, MESO = mesothelioma, NK = natural killer, OS = overall survival, OV = ovarian serous cystadenocarcinoma, PRAD = prostate adenocarcinoma, SKCM = skin cutaneous melanoma, STAD = stomach adenocarcinoma, TCGA = The Cancer Genome Atlas, THCA = thyroid carcinoma, UCEC = uterine corpus endometrial carcinoma, UVM = uveal melanoma. |\n| Keywords: CAMKK2 , immunotherapy, pan-cancer, prognosis |\n\n1. Introduction  \nCancer has emerged as the second most prominent cause of global mortality, trailing only cardiovascular disease. [1] According to the latest epidemiological studies, approximately 18 million individuals worldwide received new cancer diagnoses in 2018, and predictive models indicate an overall risk of 20.2% for developing cancer in the age range of 0 to 74 years. [2] Despite some advancements in controlling the overall mortality rate through research on cancer pathogenesis and treatments over the last 2 decades, a comprehensive understanding of its  \nbiological characteristics has not yet met the criteria of precision medicine.[3,4] The tumor’s resilience to inhibitory responses within the pathways responsible for cancer hallmarks is attributed to genomic mutations and epigenetic alterations.[5] As clinical drug development increasingly relies on gene mutations and kinase inhibition, there is a growing demand for in-depth investigations into the molecular mechanisms of tumors. Furthermore, exploring tumor immunity through in vivo and in vitro studies has highlighted the urgent necessity of identifying additional biomarkers to aid in the diagnosis and prognosis of cancer.  \nSJ and YW contributed equally to this work.  \nThis work was supported by Clinical Research Project of Zhejiang Provincial Administration of Traditional Chinese Medicine (2023ZL253).  \nThe authors have no conflicts of interest to discl","cbCaiqGBjK11aM2X","https://ap.wps.com/l/cbCaiqGBjK11aM2X","pdf",3923031,13,"English","# Abstract\n# Abbreviations\n# Introduction","[{\"question\":\"What is the main focus of this pan-cancer study on CAMKK2?\",\"answer\":\"The study evaluates the prognostic value and immunological role of CAMKK2 across multiple cancer types using multi-omics and clinical data.\"},{\"question\":\"Which cancers show notable CAMKK2 genetic or expression patterns?\",\"answer\":\"CAMKK2 shows abnormal high-frequency mutations in uterine corpus endometrial carcinoma, and relatively high expression levels in prostate adenocarcinoma.\"},{\"question\":\"How is CAMKK2 related to survival and immunotherapy outcomes?\",\"answer\":\"Aberrant CAMKK2 expression predicts survival in several cancers. In the IMvigor210 immunotherapy cohort, patients with higher CAMKK2 expression have significantly longer median overall survival, and results suggest possible survival prolongation in other cohorts as well.\"}]","The prognostic value and immunological role of calcium/calmodulin dependent protein kinase kinase 2 (CAMKK2) in pan-cancer study - Observational study | PDF",1790010781,33]